Sulphinpyrazone metabolism during long-term therapy.
Open Access
- 1 June 1981
- journal article
- Published by Wiley
- Vol. 11 (6) , 597-603
- https://doi.org/10.1111/j.1365-2125.1981.tb01176.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Two metabolites of sulphinpyrazone and their identification and determination by mass spectrometryJournal of Pharmacy and Pharmacology, 1981
- Treatment of the Patient after Myocardial InfarctionNew England Journal of Medicine, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- Two new metabolites of sulfinpyrazone in the rabbit: A possible cause of the prolonged
- Sulfinpyrazone kinetics after intravenous and oral administrationClinical Pharmacology & Therapeutics, 1979
- Determination of sulfinpyrazone and two of its metabolites in human plasma and urine by gas chromatography and selective detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1979
- The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivoThrombosis Research, 1978
- C‐Glucuronides, a Novel Type of Drug MetabolitesHelvetica Chimica Acta, 1975
- Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan®) in manEuropean Journal of Clinical Pharmacology, 1975
- Observations on G-25671, A Phenylbutazone Analogue (4-(phenylthioethyl) -1,2-diphenyl 3,5-pyrazolidinedione).Experimental Biology and Medicine, 1954